18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Trial ID or NCT#



not recruiting iconNOT RECRUITING


To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.

Official Title

18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas

Eligibility Criteria

Ages Eligible for Study: Older than 16 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Greater than 15 year-old at the time of radiotracer administration - Provides written informed consent - Suspected new diagnosis or suspected recurrence of glioma - Able to remain still for duration of each imaging procedure (about 20 minutes)
Exclusion Criteria:
  1. - Less than 15 year-old at the time of radiotracer administra - Unable to provide informed consent - Inability to lie still for the entire imaging time - Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.) - Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance


Andrei Iagaru
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Lawrence Recht, MD
Lawrence Recht, MD
Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.


Andrei Iagaru